Company Description
Koninklijke DSM NV engages in the manufacture and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. It operates through the following segments: Nutrition, Materials, Innovation Center, and Corporate Activities. The Nutrition segment serves the global industries for animal...
Koninklijke DSM NV engages in the manufacture and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. It operates through the following segments: Nutrition, Materials, Innovation Center, and Corporate Activities. The Nutrition segment serves the global industries for animal feed, food and beverage, pharmaceuticals, infant nutrition, dietary supplements, and personal care. The Materials segment deals with specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. The Innovation Center segment focuses on innovation and the growth of DSM's existing core business through adjacent technologies. The Corporate Activities segment consists of operating and service activities as well as other several costs. The company was founded in 1902 and is headquartered in Herleen, the Netherlands.
Valuation
P/E Current
14.70
P/E Ratio (without extraordinary items)
20.47
Price to Sales Ratio
3.73
Price to Book Ratio
3.70
Price to Cash Flow Ratio
24.90
Enterprise Value to EBITDA
14.14
Enterprise Value to Sales
2.87
Total Debt to Enterprise Value
0.09
Efficiency
Revenue/Employee
430,939.00
Income Per Employee
50,847.00
Receivables Turnover
5.80
Total Asset Turnover
0.60
Liquidity
Current Ratio
2.52
Quick Ratio
1.58
Cash Ratio
0.84
Profitability
Gross Margin
34.38
Operating Margin
12.46
Pretax Margin
9.94
Net Margin
11.80
Return on Assets
7.10
Return on Equity
12.99
Return on Total Capital
9.73
Return on Invested Capital
9.37
Capital Structure
Total Debt to Total Equity
33.43
Total Debt to Total Capital
24.92
Total Debt to Total Assets
19.32
Long-Term Debt to Equity
32.31
Long-Term Debt to Total Capital
24.08
Officers and Executives
Name | Age | Officer Since | Title |
---|---|---|---|
Mr. Dimitri de Vreeze | 54 | 2013 | Co-Chief Executive Officer & COO |
Ms. Géraldine Matchett | 49 | 2014 | Co-Chief Executive Officer & CFO |
Mr. Timothy A. Tolhurst | 57 | - | Chief Purchasing Officer & EVP |
Mr. Fokko Wientjes | - | 1988 | Director-Corporate Sustainable Development |
Ms. Wendy Cremers | - | - | Project Manager-Recruitment |
Insider Actions
06/04/2021 |
John Ramsay |
11 | Acquisition at $149.05 per share. | 1,639 |
06/04/2021 |
John Ramsay |
5 | Acquisition at $149.05 per share. | 745 |
03/31/2021 |
Dimitri de Vreeze |
1,850 | Acquisition at $147.4 per share. | 272,690 |
03/31/2021 |
Dimitri de Vreeze |
1,850 | Acquisition at $147.4 per share. | 272,690 |
03/31/2021 |
Géraldine Matchett |
1,850 | Acquisition at $147.4 per share. | 272,690 |
03/31/2021 |
Géraldine Matchett |
1,850 | Acquisition at $147.4 per share. | 272,690 |
03/31/2021 |
Dimitri de Vreeze |
10,962 | Award at $0 per share. | 0 |
03/31/2021 |
Dimitri de Vreeze |
10,962 | Award at $0 per share. | 0 |
03/31/2021 |
Géraldine Matchett |
10,962 | Award at $0 per share. | 0 |
03/31/2021 |
Géraldine Matchett |
10,962 | Award at $0 per share. | 0 |
03/31/2021 |
Dimitri de Vreeze |
5,167 | Disposition at $145.12 per share. | 749,835 |
03/31/2021 |
Dimitri de Vreeze |
5,167 | Disposition at $145.12 per share. | 749,835 |
03/31/2021 |
Géraldine Matchett |
4,358 | Disposition at $145.12 per share. | 632,432 |
03/31/2021 |
Géraldine Matchett |
4,358 | Disposition at $145.12 per share. | 632,432 |
11/30/2020 |
Dimitri de Vreeze |
6,000 | Acquisition at $48.91 per share. | 293,460 |
11/30/2020 |
Dimitri de Vreeze |
6,000 | Acquisition at $48.91 per share. | 293,460 |
11/30/2020 |
Dimitri de Vreeze |
6,000 | Disposition at $137.67 per share. | 826,020 |
11/30/2020 |
Dimitri de Vreeze |
6,000 | Disposition at $137.67 per share. | 826,020 |
05/08/2020 |
Dimitri de Vreeze |
12,000 | Disposition at $114.2 per share. | 1,370,400 |
05/08/2020 |
Dimitri de Vreeze |
12,000 | Disposition at $114.2 per share. | 1,370,400 |
05/08/2020 |
Dimitri de Vreeze |
12,000 | Derivative/Non-derivative trans. at $40.9 per share. | 490,800 |
05/08/2020 |
Dimitri de Vreeze |
12,000 | Derivative/Non-derivative trans. at $40.9 per share. | 490,800 |
05/08/2020 |
Thomas Leysen |
5,035 | Award at $0 per share. | 0 |
03/31/2020 |
Feike Sijbesma |
27,171 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/31/2020 |
Dimitri de Vreeze |
1,632 | Derivative/Non-derivative trans. at $105 per share. | 171,360 |
03/31/2020 |
Dimitri de Vreeze |
17,666 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/31/2020 |
Dimitri de Vreeze |
1,632 | Derivative/Non-derivative trans. at $105 per share. | 171,360 |
03/31/2020 |
Dimitri de Vreeze |
17,666 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/31/2020 |
Géraldine Matchett |
17,666 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/31/2020 |
Géraldine Matchett |
17,666 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/31/2020 |
Feike Sijbesma |
2,578 | Acquisition at $105 per share. | 270,690 |
03/31/2020 |
Géraldine Matchett |
1,558 | Acquisition at $105 per share. | 163,590 |
03/31/2020 |
Géraldine Matchett |
1,558 | Acquisition at $105 per share. | 163,590 |
03/31/2020 |
Feike Sijbesma |
12,134 | Disposition at $102.15 per share. | 1,239,488 |
03/31/2020 |
Dimitri de Vreeze |
8,326 | Disposition at $102.15 per share. | 850,500 |
03/31/2020 |
Dimitri de Vreeze |
8,326 | Disposition at $102.15 per share. | 850,500 |
03/31/2020 |
Géraldine Matchett |
6,307 | Disposition at $102.15 per share. | 644,260 |
03/31/2020 |
Géraldine Matchett |
6,307 | Disposition at $102.15 per share. | 644,260 |
03/31/2019 |
Feike Sijbesma |
3,872 | Acquisition at $97.74 per share. | 378,449 |
03/31/2019 |
Géraldine Matchett |
2,552 | Acquisition at $97.74 per share. | 249,432 |
03/31/2019 |
Géraldine Matchett |
2,552 | Acquisition at $97.74 per share. | 249,432 |
03/31/2019 |
Feike Sijbesma |
36,350 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/31/2019 |
Géraldine Matchett |
24,006 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/31/2019 |
Géraldine Matchett |
24,006 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/31/2019 |
Feike Sijbesma |
17,073 | Disposition at $98.82 per share. | 1,687,153 |
03/31/2019 |
Géraldine Matchett |
8,013 | Disposition at $98.82 per share. | 791,844 |
03/31/2019 |
Géraldine Matchett |
8,013 | Disposition at $98.82 per share. | 791,844 |
02/28/2019 |
Dimitri de Vreeze |
18,000 | Disposition at $94.44 per share. | 1,699,920 |
02/28/2019 |
Dimitri de Vreeze |
18,000 | Disposition at $94.44 per share. | 1,699,920 |
02/28/2019 |
Dimitri de Vreeze |
18,000 | Derivative/Non-derivative trans. at $46.2 per share. | 831,600 |
02/28/2019 |
Dimitri de Vreeze |
18,000 | Derivative/Non-derivative trans. at $46.2 per share. | 831,600 |
MarketWatch News on KDSKF
-
Updates, advisories and surprises
- MarketWatch
-
Royal DSM 3rd-quarter net doubled, sales up 5%
- Robert Daniel
-
- Sue Chang
-
Martek agrees to $31.50-share bid from Royal DSM
- Robert Daniel
-
Martek shares closed Monday at $23.36
- Robert Daniel
-
Royal DSM to pay total $1.09B for Martek
- Robert Daniel
-
Royal DSM to pay $31.50-shr for Martek Biosciences
- Robert Daniel
-
Martek Biosciences to be bought by Royal DSM
- Robert Daniel
Other News on KDSKF
-
DSM NV: Staying Resilient Through The Downcycle
- Seeking Alpha
-
JTD: Multi-Asset Fund Set To Get Larger, Some Appeal Here
- Seeking Alpha
-
Koninklijke DSM NV 2018 Q1 - Results - Earnings Call Slides
- Seeking Alpha
-
Koninklijke DSM NV 2017 Q4 - Results - Earnings Call Slides
- Seeking Alpha
-
Koninklijke DSM NV 2017 Q3 - Results - Earnings Call Slides
- Seeking Alpha
- Loading more headlines...